XCath
Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
About
XCath develops next-generation endovascular robotics and steerable neurovascular guidewires designed for enhanced precision in navigating the human vasculature. Their technology aims to enable expert navigation of complex anatomy, democratize access to critical care, and improve clinical outcomes for minimally invasive treatments of vascular conditions. XCath serves the medical field by providing advanced tools for endovascular procedures. Teams look it up for Medical Devices, Robotics, Healthcare.
Frequently asked
What does XCath do?
XCath is a Medical Devices company that offers Hardware. Teams look it up for Robotics, Healthcare, Biotechnology. It is based in Houston, United States and was founded in 2017. Public records show about 31 people and $54M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has XCath raised?
XCath has raised a total of $54M in funding. The most recent round on record is Series C.
Where is XCath headquartered?
XCath is headquartered in Houston, United States.
When was XCath founded?
XCath was founded in 2017.
What industry does XCath operate in?
XCath operates in Medical Devices, Robotics, Healthcare, Biotechnology, HealthTech.
How many employees does XCath have?
XCath has approximately 31 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.